Remarkably, the significance of SF3B1 extends beyond its mutation, as numerous studies have demonstrated a clear link between changes in SF3B1 expression levels and the aggressiveness of various cancers, including prostate cancer, hepatocarcinoma, and diffuse malignant peritoneal mesothelioma 28-40. Here, SF3B1 is linked to malignant peritoneal mesothelioma.